These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 27344186)
1. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis. Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186 [TBL] [Abstract][Full Text] [Related]
2. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis. Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103 [TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis. Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis. Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CIP2A expression in solid tumors: A meta-analysis. Tang M; Shen JF; Li P; Zhou LN; Zeng P; Cui XX; Chen MB; Tian Y PLoS One; 2018; 13(7):e0199675. PubMed ID: 30044786 [TBL] [Abstract][Full Text] [Related]
6. High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients. Huang A; Zhou H; Zhao H; Quan Y; Feng B; Zheng M Med Oncol; 2013 Dec; 30(4):712. PubMed ID: 24072509 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients. Villalba M; Diaz-Lagares A; Redrado M; de Aberasturi AL; Segura V; Bodegas ME; Pajares MJ; Pio R; Freire J; Gomez-Roman J; Montuenga LM; Esteller M; Sandoval J; Calvo A Oncotarget; 2016 Apr; 7(16):22752-69. PubMed ID: 26989022 [TBL] [Abstract][Full Text] [Related]
8. The upregulation of TMPRSS4, partly ascribed to the downregulation of miR‑125a‑5p, promotes the growth of human lung adenocarcinoma via the NF‑κB signaling pathway. Fan X; Liang Y; Liu Y; Bai Y; Yang C; Xu S Int J Oncol; 2018 Jul; 53(1):148-158. PubMed ID: 29750426 [TBL] [Abstract][Full Text] [Related]
9. TMPRSS4 Expression as a Marker of Recurrence in Patients with Lung Cancer. Chikaishi Y; Uramoto H; Koyanagi Y; Yamada S; Yano S; Tanaka F Anticancer Res; 2016 Jan; 36(1):121-7. PubMed ID: 26722035 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of TMPRSS4 expression in patients with breast cancer. Liang B; Wu M; Bu Y; Zhao A; Xie F Med Oncol; 2013 Jun; 30(2):497. PubMed ID: 23420063 [TBL] [Abstract][Full Text] [Related]
11. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection. Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of TMPRSS4 in prostate cancer. Shi G; Yang X; Dai B; Zhang H; Shen Y; Zhu Y; Zhu Y; Xiao W; Ma C; Wen L; Qin X; Cao D; Ye D Int J Clin Exp Pathol; 2014; 7(11):8053-8. PubMed ID: 25550850 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis. Li L; Wu D; Yu Q; Li L; Wu P Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of TMPRSS4 in gastric cancer. Sheng H; Shen W; Zeng J; Xi L; Deng L Neoplasma; 2014; 61(2):213-7. PubMed ID: 24299317 [TBL] [Abstract][Full Text] [Related]
15. TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis. Zhang Y; Cai P; Liang T; Wang L; Hu L Oncotarget; 2017 May; 8(19):31705-31713. PubMed ID: 28423646 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Larzabal L; Nguewa PA; Pio R; Blanco D; Sanchez B; Rodríguez MJ; Pajares MJ; Catena R; Montuenga LM; Calvo A Br J Cancer; 2011 Nov; 105(10):1608-14. PubMed ID: 22067904 [TBL] [Abstract][Full Text] [Related]
17. Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer. Tazawa H; Suzuki T; Saito A; Ishikawa A; Komo T; Sada H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Kuraoka K; Tashiro H J Gastrointest Surg; 2022 Feb; 26(2):305-313. PubMed ID: 34379296 [TBL] [Abstract][Full Text] [Related]
18. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis. Xu M; Xu S Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480 [TBL] [Abstract][Full Text] [Related]
19. The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis. Wang S; Wu J; Shen H; Wang J BMC Cancer; 2020 May; 20(1):471. PubMed ID: 32456621 [TBL] [Abstract][Full Text] [Related]
20. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma. Xu X; Sun T; Jing J BMC Endocr Disord; 2022 Nov; 22(1):280. PubMed ID: 36380313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]